Decabromodiphenyl oxide 99% Decabromodiphenyl oxide Decabromodiphenyl oxide CAS1163-19-5
Lorcaserin(856681-05-5)is an orally administered agent and a selective 5-HT2C receptor agonist for the treatment of obesity. It had been approved for marketing in US by FDA on 27 June in 2012. In clinical studies, lorcaserin has demonstrated efficacy in obese and overweight populations by promoting weight loss and improving metabolic parameters, and it is well tolerated.
CAS: | 1163-19-5 |
MF: | C12Br10O |
MW: | 959.17 |
Assay: | 99% |
Melting point : | >300 °C(lit.) |
Chemical Properties: | White solid |
density : | 3 g/cm3 |
Uses: |
Decabromodiphenyl ether is a brominated flame retardant that is used in conjunction with antimony trioxide in high impact polystyrene. |
CAS NO:7647-15-6
CAS NO:420-37-1
CAS NO:13598-36-2
CAS NO:97416-84-7
CAS NO:15761-39-4
CAS NO:118-75-2
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View